Articles tagged with Myocardial Infarction
A recent study found that both radial and femoral approaches for percutaneous coronary intervention (PCI) are equally effective in terms of survival rates at 30 days. The research, which enrolled nearly 2,300 patients, suggests that operators can achieve similar results with either approach if they have efficient systems and teams in p...
A new study shows that a 4 gram dose of icosapent ethyl significantly reduces the occurrence of ischemic events, including heart attacks, strokes, and related deaths. The drug also prevents subsequent cardiovascular events and may be a cost-effective way to prevent CV complications in patients with elevated triglycerides.
Researchers found that ticagrelor has comparable efficacy to clopidogrel in patients treated with clot busters for a heart attack. The trial also showed that ticagrelor is safe for use in this patient population, with low rates of major bleeding.
The REDUCE-IT trial found that high-dose icosapent ethyl significantly reduced the burden of first and subsequent cardiovascular events, including heart attacks, strokes, and deaths from cardiovascular causes. The study showed a 30% relative risk reduction in total cardiovascular events.
Patients treated with apixaban and a P2Y12 inhibitor had lower rates of bleeding and no increase in heart attacks or strokes compared to those receiving warfarin and aspirin. The combination reduced the risk of major bleeding by up to 47% without increasing mortality or hospitalization.
Researchers found that systematic depression screening after a heart attack did not impact patients' quality of life. Depression was identified in about 7% of screened patients, and interventions such as medication, phone-based psychotherapy sessions, or a combination both were shown to be effective in reducing depressive symptoms.
A Yale study of over four million Medicare patients found that hospitalizations for heart attacks have declined by 38% since the 1990s, while the 30-day mortality rate has dropped to an all-time low of 12%. These gains are attributed to national efforts to prevent heart attacks and improve care.
A study of over 27,000 heart attack patients found an increase in heat-induced heart attacks in recent years, particularly among individuals with diabetes or hyperlipidaemia. Climate change is suspected to be a contributing factor, but the exact mechanism behind these deaths remains unclear.
Researchers found that lower blood pressure is associated with increased risk of death in adults over 80, and those who've had a heart attack or stroke. This study's results suggest adjusting antihypertensive treatment based on individual needs, moving away from blanket approaches.
A study presented at the 30th Annual Conference of the Saudi Heart Association found that waterpipe and cigarette smoking are associated with heart attacks at a younger age in Saudi Arabians. Smokers have more complications, bigger heart attacks, and poorer outcomes compared to non-smokers.
A study has revealed that young adults under 40 are experiencing an alarming increase in heart attacks, despite having the same mortality rates as older survivors. Substance abuse and diabetes may be contributing to this trend, emphasizing the need for prevention and early detection of cardiovascular disease.
Researchers have discovered a potential new drug that can minimize heart muscle death caused by stress signals after a heart attack. The treatment, targeting protein MAP4K4, reduced damage by 60% in mice and has the potential to be developed into an injection for routine clinical use.
A large study of nearly 30 million hospital records shows that people who got a flu shot while hospitalized had a 10 percent lower risk of having a heart attack compared to those who didn't get vaccinated. The findings suggest that getting a flu vaccine can reduce the risk of major cardiovascular problems.
Adults who vape are significantly more likely to have a heart attack, coronary artery disease, and depression compared to non-users. The study found that e-cigarette users were 56% more likely to have a heart attack and 30% more likely to suffer a stroke.
A study found that high-intensity interval training (HIIT) was more effective than moderate exercise in losing body fat and trimming waistlines among cardiac rehabilitation patients. After 12 weeks, HIIT participants lost 4 pounds of body fat, gained 1.5 pounds of lean muscle mass, and trimmed an inch off their waists.
A study published in The BMJ found a genetic link between high testosterone levels and increased risk of blood clots, heart failure, and heart attacks in men. Researchers suggest that treatments lowering testosterone levels could help protect against these conditions, particularly in men.
A new study led by Professor Mary Schooling found that testosterone is associated with a higher risk of blood clots and heart failure in men, but not heart attack. The findings suggest targeting testosterone could be a timely new avenue for preventing ischemic cardiovascular disease.
A study of 2,564 patients who had a heart attack found that those traveling had a lower risk of long-term all-cause death if treated promptly. Patients traveling were younger and had a higher prevalence of STEMI, a serious type of heart attack.
A study found that one in four men aged 55-59 is at risk of needing further revision surgery, with serious complications surprisingly common in older people. The lifetime risk of revision surgery was highest during the first five years after surgery.
A new report reveals that over 1.2 million Australians with heart disease are at high risk of future events, emphasizing the need for improved secondary prevention strategies. The 'No Second Chances' report proposes pathways to enhance patient care, including a secondary prevention campaign and increased focus on cardiac rehabilitation.
A new study suggests that a program providing bridge care between hospital and home can reduce readmissions and deaths after a heart attack. The Heart Care Navigation Team's program assigns a health advocate and nurse navigator to help patients with timely access to follow-up care.
The European Society of Cardiology's Acute Cardiovascular Care Congress explores the best ways to save lives from heart attacks and cardiac arrests. Gender differences and stress management are also key topics discussed by leading specialists.
Researchers found that NSAID carprofen triggered low-grade inflammation in the heart and kidneys, amplifying cardiorenal syndrome. Biomarkers of kidney injury increased, indicating compromised glomerular structure integrity.
Treating psoriasis with biologic drugs has been shown to reduce early plaque buildup in arteries, restricting blood flow and leading to heart attacks and stroke. The study highlights the potential of immunotherapies in reducing cardiovascular disease risks.
Scientists successfully created functional blood vessels in vitro for rat hearts after a heart attack, resulting in increased blood flow to the engineered tissue. This innovation offers hope for treatments that could help patients regrow heart muscle tissue and achieve more complete recovery.
A new Harvard University study reveals that reducing spending on cardiovascular disease has slowed healthcare cost growth among the elderly population. The research found that investments in preventative care can produce significant savings, with nearly half of the reduction attributed to cardiovascular health.
A Lancet study found that statin therapy reduced the risk of a major vascular event by about a quarter for each millimole per litre reduction in LDL cholesterol, even in older people. Statins also did not increase the risk of deaths from non-cardiovascular disease or cancer at any age.
A new study found that e-cigarette users have a 71% higher risk of stroke, 59% higher risk of heart attack or angina, and 40% higher risk of coronary heart disease. The American Heart Association cautions against e-cigarette use due to nicotine content.
Researchers found that all Brexit scenarios would reduce fruit and veg intake, with a no-deal Brexit being the most damaging. This led to an estimated 12,400 additional CVD deaths in England between 2021 and 2030.
A new study published in the International Journal of Cardiology confirms that diets rich in palmitic and stearic acid, found in meats, increase cardiovascular risk. In contrast, eating fewer long-chain saturated fats and consuming plant-based proteins lowers the risk of myocardial infarction.
A team of researchers has identified a genetic pathway that causes some individuals to develop an abnormal heart rhythm after experiencing a heart attack. They have also discovered a drug candidate that can block this pathway.
A new study published in JAMA found that frequent aspirin use can lead to a 50% increase in major bleeding episodes. While aspirin reduces cardiovascular event risks, it increases the risk of major bleeding, making its use for initial prevention uncertain.
A study of 325,000 hospitalized heart attack patients found that Medicaid expansion reduced uninsurance rates but did not improve quality of care or outcomes for low-income adults. The lack of insurance was still associated with worse care and outcomes in both expansion and non-expansion states.
A new study published in the European Heart Journal found that individuals with higher fitness levels have a lower risk of heart attacks and angina pectoris over nine years. Even among seemingly healthy individuals, those with optimal fitness have only half as high a risk as those with poor fitness.
A new study has found a genetic factor on chromosome 6 that increases the risk of spontaneous coronary artery dissection (SCAD), a rare and atypical form of heart attack primarily affecting young to middle-aged women. The genetic variant, known as rs9349379, is also associated with a small protective effect from classic heart attacks.
Researchers found a significant association between cancer development and an elevated risk of heart attack and stroke in the months leading up to the diagnosis. The risk was highest for patients with lung and colorectal cancers and those diagnosed with stage 3 or 4 disease, peaking in the month before diagnosis.
An observational study found that HRRP implementation was associated with increased 30-day postdischarge mortality for heart failure and pneumonia patients. However, no association was seen for patients hospitalized for heart attack.
A Swedish study found that the risk of heart attack peaks at around 10 pm on Christmas Eve, especially for older and sicker individuals due to heightened emotional stress. This risk is also higher during New Year's and Midsummer holidays, as well as Monday mornings.
Scientists at the Peter Munk Cardiac Centre have discovered that macrophage cells play a crucial role in helping the heart repair and regenerate following a heart attack. The study found that these cells can act in a neo-natal-like state, aiding in tissue growth and development.
A comprehensive statistical modeling study found that statins are recommended far too often, with the benefits outweighing the harms only in people with a high risk of cardiovascular disease. The researchers recommend discussing individual risk and side effects with doctors before taking statins as a preventive measure.
Researchers at the University of Otago have discovered blocking oxytocin cells in the brain after a heart attack can improve survival outcomes. The breakthrough could lead to a new pharmacological drug targeting these cells, potentially improving cardiovascular patient outcomes.
Researchers at the Hubrecht Institute found that adult hearts do not have stem cells that can regenerate lost heart muscle after a heart attack. Instead, connective tissue cells produce scar tissue to replace the lost cardiac muscle, which helps maintain heart integrity.
Researchers found that younger patients with repeat heart attacks had a higher prevalence of modifiable risk factors, including smoking and high blood pressure. Secondary preventive programs targeting these risk factors can help prevent future heart attacks in this age group.
Engineered patches integrate therapeutic cardiac cells with injured heart tissue, boosting development of new heart tissue and increasing cardiac functions. The treatment shows promise as a form of cardiac therapy in humans, offering hope for survivors of heart attacks.
A study found top-ranked hospitals for cardiovascular care had lower 30-day mortality rates for heart attack, heart failure, and CABG compared to non-ranked hospitals. However, readmission rates were either similar or higher at the top-ranked hospitals, raising concerns about the accuracy of this metric.
A study of 7,026 patients found that persistent high residual inflammatory risk after percutaneous coronary intervention is associated with a higher risk of death from any cause or myocardial infarction within one year. High sensitivity C-reactive protein levels were used to assess the level of risk.
Researchers discovered how filamin A and Drp1 interact to facilitate mitochondrial fission under hypoxic conditions, leading to heart failure. The study found that cilnidipine prevents this damaging process, preserving heart function after a heart attack or in cardiovascular disease.
Research studies by Cedars-Sinai's Sumeet Chugh's team identify associations between sudden cardiac arrest and multiple sclerosis, left ventricular hypertrophy, and obesity. Patients with MS have a five-fold higher incidence of sudden cardiac arrest, while those with LVH are at higher risk due to electrocardiography risk scores.
A new study found that patients with bacterial pneumonia are at a 60% greater risk of a heart attack, stroke, or death compared to those with viral pneumonia. Researchers recommend aggressive treatment and close monitoring for patients with bacterial pneumonia, particularly those with pre-existing heart conditions.
A new study found that a smartphone app can identify potentially fatal heart attacks with high accuracy, similar to a standard 12-lead ECG. The app's speed and accessibility could significantly improve treatment times and save lives.
The VITAL study found that omega-3 fatty acids reduced the risk of heart attacks, particularly among African American participants. Vitamin D supplements may also lower cancer deaths over time, with a significant 25% reduction in mortality rates observed after two years of treatment.
A UK Biobank study found that certain risk factors have a greater impact on women's heart attack risk than men's. High blood pressure, smoking, and diabetes increased the risk of heart attack more in women than in men.
A study of 472,000 participants found that women with these conditions experience a higher relative risk of heart attack compared to men. The excess risk persists even in older age and could lead to an additional burden on society.
A large international clinical trial found that alirocumab, a PCSK9 antibody, reduced the chance of additional heart problems or stroke in heart attack survivors. LDL cholesterol levels decreased by 50% with alirocumab treatment, leading to a 15% reduction in risk of death from coronary heart disease, another heart attack, or stroke.
Researchers found that people with high levels of chronic noise exposure had a greater than three-fold risk of cardiovascular events. Chronic noise exposure fuels blood vessel inflammation, promoting cardiac risk.
Researchers analyzed data from 6,400 patients with heart attacks to compare characteristics and survival rates by race. The study found no differences in survival rates between black and white patients with similar characteristics.
A comprehensive study by the Swiss Tropical and Public Health Institute found that air pollution and transportation noise significantly increase the risk of heart attacks. The study reveals that considering both factors together reduces the estimated effect of air pollution on cardiovascular health.
Researchers at Karolinska Institutet discovered high levels of antiphospholipid antibodies in patients who suffered a heart attack without any autoimmune conditions. The study involved 800 patients and found that 11% had elevated IgG antibody levels, which is associated with blood clots.
A new blood test at emergency departments could quickly and accurately rule out heart attacks. A preliminary study of 350 patients found the test to be as effective as longer laboratory tests in ruling out heart attacks.
A large-scale study found that bariatric surgery significantly reduces the risk of heart attacks, strokes, and deaths in individuals with type 2 diabetes and severe obesity. The study involved over 5,000 patients who underwent bariatric surgery compared to nearly 15,000 patients receiving usual medical care.